8-K: Avenue Therapeutics Stockholders Approve Directors, KPMG

Avenue Therapeutics, Inc. announced that its stockholders approved the election of six directors and ratified KPMG LLP as its independent auditor for 2025 at the annual meeting.

Summary

• Avenue Therapeutics, Inc. held its 2025 annual meeting of stockholders virtually on December 30, 2025.
• Stockholders approved the election of six directors to hold office until the 2026 annual meeting of stockholders.
• Stockholders ratified the appointment of KPMG LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025.
• The record date for determining stockholders entitled to vote was November 25, 2025.
• As of the record date, 3,183,426 shares of Common Stock (with 3,183,426 votes) and 250,000 shares of Class A Preferred Stock (with 3,500,000 votes) were outstanding and eligible to vote.
• All six director nominees received overwhelming 'For' votes, ranging from 3,861,508 to 3,862,060 votes.
• The ratification of KPMG LLP as the independent auditor passed with 3,862,335 'For' votes, 104,651 'Against' votes, and 1,010 abstentions.

Sentiment

Score: 7

Explanation: The successful approval of all proposals, including the election of directors and the ratification of the independent auditor, indicates stable corporate governance and stockholder alignment, which is a moderately positive signal for company stability.

Positives

• All proposed matters, including the election of directors and the ratification of the independent auditor, were approved by stockholders.
• The strong stockholder support for the board of directors and the independent auditor indicates stable corporate governance and alignment.

Future Outlook

The elected directors will serve until the 2026 annual meeting of stockholders. KPMG LLP will serve as the independent registered public accounting firm for the year ending December 31, 2025.

Industry Context

This filing represents a routine corporate governance event, common across publicly traded companies, ensuring accountability and oversight through stockholder participation in key decisions like board composition and auditor selection. The successful approval of these proposals indicates standard adherence to governance practices within the industry.

Corporate Governance

Stakeholder Impact

• Shareholders: Directly participated in and approved key governance decisions, ensuring their representation and oversight in the company's direction.
• Management/Board: Received a mandate from stockholders to continue their roles and strategic oversight, indicating confidence in current leadership.

Next Steps

• The elected directors will serve until the 2026 annual meeting of stockholders.
• KPMG LLP will continue as the independent registered public accounting firm for the fiscal year ending December 31, 2025.

Key Dates

Keywords

Avenue Therapeutics, ATXI, SEC filing, 8-K, annual meeting, stockholder vote, corporate governance, director election, KPMG, auditor ratification, common stock, preferred stock